TiumBio, a Biotech Company Gets Selected as One of Outstanding Startups at the Super Gap Startup 1000+ Tech Conference
The Ministry of SMEs and Startups (Minister Lee Young) held the "Super Gap Startup 1000+ Tech Conference" for two days ...
Tag: biotech
Korea to support the domestic biotech sector in generating $76.9 billion by 2030
The South Korean government has announced its support for the domestic biotech sector, with the aim of increasing its production ...
Celltrion to develop oral autoimmune disease treatment with US firm
Celltrion, a leading biopharmaceutical company in South Korea, has partnered with Rani Therapeutics, a US-based clinical-stage biotech company. According to ...
South Korea to ease regulations for data-driven healthcare startups
South Korea is planning to nurture the biotechnology industry as a new economic growth engine. Choo Kyung-ho, Korea’s Finance Minister, ...
South Korea announces ‘Global Innovation Zone Plan’, plans 10 innovation special zones by 2027
On Monday, South Korea's Ministry of Small and Medium-sized Enterprises (SMEs) and Startups announced the 'Global Innovation Special Zone Creation ...
AMSBIO to revolutionize Korea’s diagnostic market with saliva-based cancer diagnosis technology
South Korean In Vitro Diagnostics (IVD) medical device, and diagnostic reagent developer, AMSBIO is looking forward to building a new ...
South Korean Firms to Inject 10 Trillion Won into Biotechnology by 2023
South Korean biotech companies, including Celltrion and Samsung Biologics, would jointly invest a total of 10 trillion won ($9.03 billion) ...
SK Holdings Injects 8 Billion Won in Hummingbird Bioscience in Series B
SK Holdings on Monday said that it injected 8 billion won ($6.5 million) in Hummingbird Bioscience to secure novel antibody-based ...
LegoChem Biosciences Signs 496.3 Bln Won Licensing Deal with UK Iksuda
LegoChem Biosciences Inc. announced it signed a 496.3 billion won ($405 million) worth agreement on licensing out its antibody-drug conjugate ...
Samsung Biologics, Aprinoia Inks Deal to Develop Alzheimer’s Treatment
Samsung Biologics announced on Tuesday that it signed a contract with Aprinoia Therapeutics to develop the Taiwan-based biotech firm's Alzheimer's ...
